Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

2014437 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 15, Issue 3, pp. 305-314

Field-Weighted Citation Impact: 32.31